Elemental Impurities: A Review
DOI:
https://doi.org/10.37591/(rrjops).v11i1.671Keywords:
Elemental Impurities, Risk assessment, Control Limits, Strategy, Analytical, ICHAbstract
The ICH Q3D is an important guideline to harmonize control of elemental impurities. The guideline sets strict limits for final drug products, limits for excipients, active pharmaceutical ingredients and other pharmaceutical drug products. The analysis of elemental impurities in the pharmaceutical products is most important in pharmaceutical industries. In the last decade noteworthy progress has been made in the analysis of elemental impurities. The changes from using special reagents which form precipitate with the metallic impurities and are detected by colorimetric methods to using highly sophisticated instruments for analysis. This review article will cover in brief about the classes of elemental impurities, their permitted daily exposures, concentrations, risk assessment, control strategies and instruments used for analytical testing. With the risk assessment approach, the contribution of elemental impurities of each component is assessed. The option 1 limit (based on 10 g daily dose) may be used as default concentration limit. This approach allows manufacturers to provide crucial information about the contribution of impurities in final drug products from excipients or active pharmaceutical ingredients.
Keywords:
Analytical, control limits, elemental impurities, ICH, risk assessment, strategy
Cite this Article
Vaibhav S. Adhao, Raju R. Thenge. Elemental Impurities: A Review. Research and Reviews: A Journal of Pharmaceutical Science. 2020; 11(1): 17–21p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |